FindTrial
Sign In

A study for postoperative pain relief using two drugs in combination in patients undergoing arthroscopic shoulder surgery.

Postoperative pain relief in arthroscopic shoulder surgery with ultrasound guided interscalene block with ropivacaine and fentanyl combination using two techniques- A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013671
Enrollment
50
Registered
2018-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients fit for shoulder surgeries

Interventions

Intervention1: injection dexamethasone,injection ropivacaine, injection fentanyl: Patients will receive a single shot of intravenous injection dexamethasone 8 mg and perineural patient controlled bolu

Sponsors

Department of Anaesthesia and Intensive Care
Lead Sponsor
Department of Orthopaedics
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I-II BMI â?? 18-30 kg/m2 Undergoing Arthroscopic shoulder surgery such as rotator cuff injury repair, recurrent shoulder dislocations, superior labrum anterior and posterior (SLAP lesion), acromioplasty, labral cyst removal.

Exclusion criteria

Exclusion criteria: Patient refusing to give informed consent History of relevant drug allergy History of psychiatric illness, substance abuse Severe cardiovascular, respiratory, metabolic or neurological disease Pregnancy and lactation Coagulopathy Contralateral phrenic nerve dysfunction Infection at planned injection site Patients on steroids

Design outcomes

Primary

MeasureTime frame
Mean postoperative pain score measured by numeric rating scale(NRS) over 48h study period.Timepoint: Mean NRS pain score between the two groups over 48h study period at time intervals of 1,4,12,24,36,48h.—

Secondary

MeasureTime frame
Difference in total analgesic consumption, rescue analgesic use, manual muscle test scoring, patient satisfaction and adverse effects if any. Timepoint: Difference in total analgesic consumption, rescue analgesic use, manual muscle test scoring, patient satisfaction and adverse effects if any checked at intervals of 1,4,12,24,36,48 hour time period.—

Countries

India

Contacts

Public ContactProf Sukanya Mitra

Government Medical College and Hospital Sector-32 Chandigarh

drsmitra12@yahoo.com9646121521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026